Fosun Pharmaceu...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Concert Pharmaceuticals
Fosun Pharmaceutical bought Concert Pharmaceuticals
1/19/23 at 17:11
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.
Concert Pharmaceuticals
Review
Source:
ir.concertpharma.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Phosagro reports for 2024 by IFRS
2/13/25
PHOR
EL5-Energo's generation in 2024 increased by 7.1%
2/13/25
ELFV
Board of Directors of Cherkizovo Group recommended that dividends be paid for 2024
2/13/25
GCHE
Cherkizovo reports for 2024 by IFRS
2/13/25
GCHE
Digital Habits JSC will continue to collect applications for Pre-IPOs
2/13/25
OTCI
Promomed records double-digit sales growth in January
2/13/25
PRMD
QIWI became NanduQ
2/13/25
QIWI
SPB Exchange expands the list of securities for weekend trading
2/13/25
SPBE
Moscow Exchange starts testing weekend trading
2/12/25
MOEX
KVLZ Kristall increased sales by 2.2 times
2/12/25
KLVZ
«
Previous
13
14
15
16
17
18
19
20
21
22
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)
ir.concertpharma.com ir.concertpharma.com ir.concertpharma.com
English (US) 